RENEDIL SRT 5MG DIN 00864013
Health Canada record
| Active ingredient(s) | FELODIPINE 5 MG |
|---|---|
| Dosage form | Tablet (Extended-Release) |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C08CA02 FELODIPINE |
| Original market date | 31-Dec-1992 |
| Current status date | 29-Aug-1996 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FELODIPINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02452375 | APO-FELODIPINE | APOTEX INC | Tablet (Extended-Release) | FELODIPINE 5 MG | Marketed |
| 02452367 | APO-FELODIPINE | APOTEX INC | Tablet (Extended-Release) | FELODIPINE 2.5 MG | Marketed |
| 02452383 | APO-FELODIPINE | APOTEX INC | Tablet (Extended-Release) | FELODIPINE 10 MG | Marketed |
| 00851779 | PLENDIL | GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE | Tablet (Extended-Release) | FELODIPINE 5 MG | Marketed |
| 00851787 | PLENDIL | GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE | Tablet (Extended-Release) | FELODIPINE 10 MG | Marketed |
| 02057778 | PLENDIL | GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE | Tablet (Extended-Release) | FELODIPINE 2.5 MG | Marketed |
| 02280272 | SANDOZ FELODIPINE | SANDOZ CANADA INCORPORATED | Tablet (Extended-Release) | FELODIPINE 10 MG | Marketed |
| 02280264 | SANDOZ FELODIPINE | SANDOZ CANADA INCORPORATED | Tablet (Extended-Release) | FELODIPINE 5 MG | Marketed |
| 02240307 | ALTACE PLUS FELODIPINE 2.5MG + 2.5MG | SANOFI-AVENTIS CANADA INC | Tablet | FELODIPINE 2.5 MG; RAMIPRIL 2.5 MG | Cancelled Post Market |
| 02240306 | ALTACE PLUS FELODIPINE 5MG + 5MG | SANOFI-AVENTIS CANADA INC | Tablet | FELODIPINE 5 MG; RAMIPRIL 5 MG | Cancelled Post Market |
| 02221993 | RENEDIL | SANOFI-AVENTIS CANADA INC | Tablet (Extended-Release) | FELODIPINE 5 MG | Cancelled Post Market |
| 02221985 | RENEDIL | SANOFI-AVENTIS CANADA INC | Tablet (Extended-Release) | FELODIPINE 2.5 MG | Cancelled Post Market |
| 02222000 | RENEDIL | SANOFI-AVENTIS CANADA INC | Tablet (Extended-Release) | FELODIPINE 10 MG | Cancelled Post Market |
| 00864021 | RENEDIL SRT 10MG | HOECHST CANADA INC. | Tablet (Extended-Release) | FELODIPINE 10 MG | Cancelled Post Market |
| 01989596 | RENEDIL SRT 10MG | HOECHST ROUSSEL CANADA INC. | Tablet (Extended-Release) | FELODIPINE 10 MG | Cancelled Post Market |
| 02057786 | RENEDIL SRT 2.5MG | HOECHST CANADA INC. | Tablet (Extended-Release) | FELODIPINE 2.5 MG | Cancelled Post Market |
| 02069539 | RENEDIL SRT 2.5MG | HOECHST ROUSSEL CANADA INC. | Tablet (Extended-Release) | FELODIPINE 2.5 MG | Cancelled Post Market |
| 01989618 | RENEDIL SRT 5MG | HOECHST ROUSSEL CANADA INC. | Tablet (Extended-Release) | FELODIPINE 5 MG | Cancelled Post Market |
International API supply for FELODIPINE
8 valid EDQM Certificates of Suitability from 8 holders. 8 active FDA Drug Master Files.
Request a quote for RENEDIL SRT 5MG